Biopharma race against COVID-19
Updated: Mar 24, 2020
As the Biopharma industry in trying to match the pace of the outbreak, let's recap what are industry’s attempts to fight the pandemic.
While Moderna, BioNtech and a few others are racing for COVID-19 vaccine, main treatment hopes are 70-year old Chloroquine, anti-viral Remdesivir, TAK-888 and RNAi therapeutics.
Enabling Biopharma industry to win against this pandemic is critical.
See also, vaccine candidates: